These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16194466)

  • 1. [Recurrent signet-ring cell gastric carcinoma evidenced by FDG-PET].
    Ruiz-Hernández G; Delgado-Bolton RC; Rubio-Pérez MJ; Jiménez-Vicioso A; Pérez-Castejón MJ; Carreras-Delgado JL
    Rev Esp Med Nucl; 2005; 24(5):326-30. PubMed ID: 16194466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-body PET with FDG for the diagnosis of recurrent gastric cancer.
    De Potter T; Flamen P; Van Cutsem E; Penninckx F; Filez L; Bormans G; Maes A; Mortelmans L
    Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):525-9. PubMed ID: 11914891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Malignant tumor with false negative 18F-FDG PET image].
    Dong MJ; Lin XT; Zhao J; Guan YH; Zuo CT; Chen X; Dai JZ; Jiang BD
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):713-7. PubMed ID: 17274383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography.
    Chen J; Cheong JH; Yun MJ; Kim J; Lim JS; Hyung WJ; Noh SH
    Cancer; 2005 Jun; 103(11):2383-90. PubMed ID: 15856477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of recurrent gastric malignancy with [F-18]-FDG positron emission tomography.
    Jadvar H; Tatlidil R; Garcia AA; Conti PS
    Clin Radiol; 2003 Mar; 58(3):215-21. PubMed ID: 12639527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDG PET imaging of signet-ring cell adenocarcinoma of the stomach.
    Buyyounouski MK; Klump WJ; Konski A; Wu H; Adler LP
    Clin Nucl Med; 2005 Feb; 30(2):118-9. PubMed ID: 15647683
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical implication of FDG-PET in advanced gastric cancer with signet ring cell histology.
    Pak KH; Yun M; Cheong JH; Hyung WJ; Choi SH; Noh SH
    J Surg Oncol; 2011 Nov; 104(6):566-70. PubMed ID: 21671462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical usefulness of F-18 FDG PET in lymphoepithelioma-like gastric carcinoma.
    Park S; Lee D; Lee KM; Han SU; Lee JH; Lee SJ; An YS; Yoon JK
    Eur J Radiol; 2017 Sep; 94():160-166. PubMed ID: 28712702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
    Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G
    Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should 18F-FDG PET/CT Be Routinely Performed in the Clinical Staging of Locally Advanced Gastric Adenocarcinoma?
    Perlaza P; Ortín J; Pagès M; Buxó E; Fernández-Esparrach G; Colletti PM; Rubello D; Mayoral M; Sánchez N; Ruiz C; Ginés A; Fuster D
    Clin Nucl Med; 2018 Jun; 43(6):402-410. PubMed ID: 29485442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 18 F-FDG and 18 F-FAPI PET/CT Findings of Signet-Ring Cell Carcinoma of the Stomach.
    Zhao M; Zhang A; Zu M; Ma Y; Ding S; Zhang W
    Clin Nucl Med; 2024 Mar; 49(3):e139-e140. PubMed ID: 38271264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma.
    Ozkan E; Soydal C; Kucuk ON; Ibis E; Erbay G
    Nucl Med Commun; 2011 Dec; 32(12):1162-8. PubMed ID: 21946617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary Tumor ¹⁸F-FDG Avidity Affects the Performance of ¹⁸F-FDG PET/CT for Detecting Gastric Cancer Recurrence.
    Kim SJ; Cho YS; Moon SH; Bae JM; Kim S; Choe YS; Kim BT; Lee KH
    J Nucl Med; 2016 Apr; 57(4):544-50. PubMed ID: 26678615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of FDG-PET/CT in follow-up of patients treated with resective gastric surgery for tumour.
    Graziosi L; Bugiantella W; Cavazzoni E; Cantarella F; Porcari M; Baffa N; Donini A
    Ann Ital Chir; 2011; 82(2):125-9. PubMed ID: 21682102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasound findings of diffuse metastasis of gastric signet-ring-cell carcinoma to the thyroid gland.
    Morita K; Sakamoto T; Ota S; Masugi H; Chikuta I; Mashimo Y; Edo N; Tokairin T; Seki N; Ishikawa T
    J Med Ultrason (2001); 2017 Jan; 44(1):133-139. PubMed ID: 27696013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of (18)F-FDG PET/CT as a postoperative surveillance imaging modality for asymptomatic advanced gastric cancer patients.
    Lee DY; Lee CH; Seo MJ; Lee SH; Ryu JS; Lee JJ
    Ann Nucl Med; 2014 Oct; 28(8):789-95. PubMed ID: 24965850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on 18F-FDG PET.
    Yun M; Choi HS; Yoo E; Bong JK; Ryu YH; Lee JD
    J Nucl Med; 2005 Jun; 46(6):953-7. PubMed ID: 15937305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship Between 18F-FDG PET/CT Findings and HER2 Expression in Gastric Cancer.
    Chen R; Zhou X; Liu J; Huang G
    J Nucl Med; 2016 Jul; 57(7):1040-4. PubMed ID: 26966162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18 F-fluorodeoxyglucose positron emission tomography to evaluate recurrent gastric cancer: a systematic review and meta-analysis.
    Wu LM; Hu JN; Hua J; Gu HY; Zhu J; Xu JR
    J Gastroenterol Hepatol; 2012 Mar; 27(3):472-80. PubMed ID: 21916986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.